Soleno Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Hi, good morning, everybody, and welcome to the Cantor Global Healthcare Conference 2023. I'm Kristen Kluska, one of the analysts. It's my great pleasure to introduce Dr. Anish Bhatnagar, the CEO of Soleno Therapeutics, who I think has set the new standard for how to properly start a Cantor Healthcare Conference.
Thank you, Kristen. Good morning, everyone. Thank you all for being here today. I know that we just put out a press release with new data, and I'm sure you want to hear that first. But for the sake of those who don't know the story, I'm going to walk a little bit through the basics, how we got where we got to, and then I'll take a couple of questions.
So our forward-looking statement slide.
I want to talk a little bit about the disease Prader-Willi syndrome. So PWS is a genetic disease. It happens spontaneously in about 1 in 15,000 live births. It's typically not inherited. Translates to about between 10 and 20,000 patients in the US and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
